Joseph Vazzano's most recent trade in Abeona Therapeutics Inc was a trade of 17,795 Common Stock done at an average price of $6.8 . Disclosure was reported to the exchange on June 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.76 per share. | 06 Jun 2025 | 17,795 | 491,246 (0%) | 0% | 6.8 | 120,294 | Common Stock |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 13,333 | 504,579 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.29 per share. | 14 Mar 2025 | 685 | 509,041 (0%) | 0% | 5.3 | 3,624 | Common stock |
| Allarity Therapeutics Inc | Joseph W. Vazzano | Director | 22 Jan 2025 | 25,000 | 25,000 | - | - | Stock Options | ||
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 144,509 | 509,726 (0%) | 0% | 0 | Common stock | |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.89 per share. | 28 Sep 2024 | 6,388 | 365,217 (0%) | 0% | 5.9 | 37,625 | Common stock |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.11 per share. | 21 Jul 2024 | 1,055 | 371,605 (0%) | 0% | 5.1 | 5,391 | Common stock |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 155,200 | 372,660 (0%) | 0% | 0 | Common stock | |
| Abeona Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.52 per share. | 05 Jun 2024 | 16,408 | 217,460 (0%) | 0% | 4.5 | 74,164 | Common stock |
| Abeona Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.14 per share. | 25 Apr 2024 | 5,608 | 233,868 (0%) | 0% | 3.1 | 17,609 | Common stock |
| Abeona Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.14 per share. | 15 Mar 2024 | 703 | 228,260 (0%) | 0% | 8.1 | 5,722 | Common stock |
| Abeona Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.73 per share. | 24 Jul 2023 | 1,187 | 235,179 (0%) | 0% | 3.7 | 4,428 | Common stock |
| Abeona Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 141,908 | 236,366 (0%) | 0% | 0 | Common stock | |
| Abeona Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Mar 2023 | 792 | 94,458 (0%) | 0% | 2.6 | 2,059 | Common stock |
| Abeona Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 18 Nov 2022 | 2,500 | 95,250 (0%) | 0% | 4 | 10,000 | Common stock |
| Abeona Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2022 | 72,750 | 92,750 (0%) | 0% | 0 | Common stock | |
| Abeona Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2022 | 12,000 | 20,000 (0%) | 0% | 0 | Common stock | |
| Abeona Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 200,000 | 200,000 (0%) | 0% | 0 | Common stock | |
| Avenue Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 100,505 | 165,757 (0%) | 0% | 0 | Common Stock | |
| Avenue Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.62 per share. | 15 Sep 2021 | 7,160 | 65,252 (0%) | 0% | 1.6 | 11,599 | Common Stock |
| Avenue Therapeutics Inc | Joseph Vazzano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.13 per share. | 20 Aug 2020 | 3,840 | 57,412 (0%) | 0% | 12.1 | 46,579 | Common Stock |